Show simple item record

dc.contributor.advisorBradley L. Pentelute.en_US
dc.contributor.authorLu, Zeyu (Zeyu Mike)en_US
dc.contributor.otherMassachusetts Institute of Technology. Department of Chemistry.en_US
dc.date.accessioned2019-03-11T19:37:00Z
dc.date.available2019-03-11T19:37:00Z
dc.date.copyright2018en_US
dc.date.issued2018en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/120906
dc.descriptionThesis: Ph. D., Massachusetts Institute of Technology, Department of Chemistry, 2018.en_US
dc.descriptionCataloged from PDF version of thesis.en_US
dc.descriptionIncludes bibliographical references.en_US
dc.description.abstractThe intracellular delivery of therapeutic biomolecules such as oligonucleotides and proteins remains a key challenge today. Protective antigen, a naturally evolved protein translocase derived from Bacillus anthracis, has shown promise as a platform of protein delivery due to its ability to form a transmembrane pore that allows the cargo to have cytosolic access. We and others have used the LFN/PA system to deliver a wide variety of natural and non-natural peptides and proteins. Despite the significant progress made with the LFN/PA delivery platform, some aspects including cargo selection and targeting still remain limited. In the first part of the thesis, we greatly expand the application of the platform by demonstration of efficient delivery of peptide nucleic acids (PNAs), an oligonucleotide analog. Using this technology, we successfully exploited a cancer- specific gene dependency by the intracellular delivery of an anti-sense PNA in a receptor-dependent manner. In addition to exploiting new types of cargo for delivery, we developed a new strategy to target the LFN/PA system to specific cell types. In the second part of the thesis, we chemically conjugated a full-length immunoglobulin G (IgG) to a mutant PA (mPA). Significantly, we took advantage of the fact that PA activation is protease-dependent and created highly specific delivery vehicles that can only be activated by the concurrent presence of two entities on the cell surface. We showed a protein toxin delivered by these IgG-mPA variants effectively inhibited cell growth in different cancer cell lines and exhibited a significantly increased therapeutic window over previously reported PA variants both in vitro and in vivo. In the last part of the thesis, we explored the possibility of simplifying the LFN/PA system by directly ligating protein cargos to PA. In the absence of LFN, the chemically created single-component system significantly increased the amount of delivered cargo. Moreover, the single-component system combined with a short N-terminal polylysine tag further improved the delivery efficiency by more than 100-fold. Our findings raise the prospect of a simpler PA-mediated delivery platform..en_US
dc.description.statementofresponsibilityby Zeyu (Mike) Lu.en_US
dc.format.extent165 pagesen_US
dc.language.isoengen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsMIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582en_US
dc.subjectChemistry.en_US
dc.titleProtective antigen-mediated delivery of biomoleculesen_US
dc.typeThesisen_US
dc.description.degreePh. D.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemistry
dc.identifier.oclc1088900573en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record